Cytodyn Inc (CYDY)

[Blane]

Gilead paid 11.2B for Pharmasset in order to nab their Hep C med, Sovaldi. Think about that. Just. Hep. C.

They had other drugs, but the one that Gilead was after and knew would make the $$ was Sovaldi alone.

And they literally earned that back in the first year of sales.

https://www.google.com/amp/s/www.nytimes.com/2015/02/04/business/sales-of-sovaldi-new-gilead-hepatitis-c-drug-soar-to-10-3-billion.amp.html

https://en.m.wikipedia.org/wiki/Pharmasset

I personally believe that Nader will not accept a buyout this quickly or cheaply. He has always talked about shareholder value, and I believe he would more likely piece meal each indication, with upfront cash to see each one to the finish. By the time next year rolls around, HIV profits could likely secure future indications getting to the finish. For each indication, we can skip phase I, because it’s been taken care of. That means that it could also be a phase 2/3 combo for each indication, which can lower the cost as well.

This will be interesting to see how this plays out.

Just my opinion!